Peter N. Amponsah is an Associate Professor of Journalism and the Head of the Department of Journalism and Communication Sciences at the Catholic University of Ghana, Fiapre. He obtained his PhD in Journalism from the Southern Illinois University at Carbondale and a Master’s in Social Communications from Università Pontificia Salesiana, Rome. He received his Postgraduate Diploma from the School of Communication Studies at the University of Ghana, Legon. His research interests include communication law, ethics and policy, digital image processing, and gender equality in economic markets.

Dedicated Researcher

Daniel Tinyogtaa Adama is currently pursuing a Ph.D. in Human Sciences, specializing in Leadership Studies at the Department of Agricultural Leadership, Education, and Communication at the University of Nebraska-Lincoln. He holds a Master of Philosophy (M.Phil.) degree in Curriculum Studies and a Bachelor of Education (B.Ed. Hons.) degree in English, both earned from the Catholic University of Ghana. He is also a Project Management Consultant with the Institute of Project Management Professionals Ghana. Before his academic pursuits at UNL, he served as the Executive Director of Rural Education Support Trust and worked as Project Coordinator of Don Musso Educational Village in Ghana. Daniel is a proud Mandela Washington Fellow, having completed this prestigious program at Indiana University Bloomington.

Daniel Kwabena Obeng-Ofori is a Professor of Applied Biology and Agricultural Entomology, and a distinguished University Administrator. Professor Obeng-Ofori was born in Berekum in the Berekum East Municipality of the Bono region of Ghana. He stayed with his parents, the late OP. Daniel Obeng Kwame Abosi) and the late Obaapayin Mary Twumwaa (Akosua Kuma) who were farmers at a hamlet called Kwasi Korangkrom near Adantia in the Sunyani West District. During his childhood years and vacation periods at the village, Prof. Obeng-Ofori engaged in all sorts of farming and other incoming generating chores including establishment and maintenance of food crops and cocoa farms, palm wine tapping, distillation of Akpeteshie, hunting of rodents, and as farm labourer for weeding and harvesting of crops to obtain funds for payment of his school fees.

Appointed: October 2020 Other appointments: Chief Executive Officer of IG Group Holdings plc. Member of the Board of Advisers of the London Technology Club. Past appointments: Served as a Non-Executive Director of IG Group Holdings plc from 2015 until the time of her appointment as Chief Executive Officer in October 2018. Previously held various executive management positions at a number of large multinational businesses in Hong Kong, London and New York, including Verifone, IBM, Citibank and Chase Manhattan. Earlier in her career, was a strategy consultant with Booz Allen Hamilton. Nationality: American

Appointed: April 2013 Other appointments: Non-Executive Director of Associated British Foods plc. Past appointments: Chair of FirstGroup plc until July 2019. Chief Executive Officer of Intertek Group plc from 2005 until 2015. Prior to that he was Chief Executive Officer of TÜV Sud AG between 1998 and 2002 and Chief Executive Officer of TÜV Product Service GmbH for ten years. Formerly a Non-Executive Director of Logica plc. Education: Holds a master’s degree in Medicine from Ludwig-Maximilian-University Munich and a Medical Doctorate from Technical University Munich. Nationality: German

Other appointments: Non-Executive Director of Rolls-Royce Holdings plc. Past appointments: Prior to joining the Group was Group Finance Director of Centrica plc from 2007. Before that was Chief Financial Officer at The Peninsular & Oriental Steam Navigation Company (P&O) and its affiliated companies, having previously held a number of senior finance roles at P&O. Began his career as an accountant with KPMG. Formerly a Non-Executive Director of QinetiQ Group plc and Lloyds Banking Group plc. Education: Has a degree in Mathematics from Oxford University and is a qualified UK Chartered Accountant. Nationality: British

I am responsible for: Academic teaching support and the coordination of technical input to all pre-clinical teaching in the Medical Sciences Teaching Centre (MSTC) Building management of the MSTC. Assisting with conferences, events, teaching and administration

I am responsible for communications around the strategic research themes: Global Health, Immunology and Metabolic, in this I work as part of the Medical Sciences Division Communications Team and Research team. I actively raise the profile and visibility of the research themes both internally and externally. I create new and engaging website content and social media posts, write copy for internal communications, assist with promoting events, support the development of thematic networks, and identify opportunities to progress the team’s objectives. I also manage @OxImmuno Twitter account, promoting research, news, events, and activities from the Immunology network. I have over 10 years of experience in communications working across a variety of fields such as social sciences and environmental advocacy and countries such as the USA, India and Germany.

REGIUS PROFESSOR OF MEDICINE Shared responsibility with the Head of Division for recruitment to senior academic positions. Leads the development of the Division’s research strategies Plays a major role in external relations, including those with major research funding agencies, charities and industry

Professor Simon Draper leads the Blood-Stage Malaria Vaccine group, based at the Jenner Institute, University of Oxford and is a Wellcome Trust Senior Fellow. He researches potential malaria vaccines, which aim to induce immunity to the malaria parasite while it is in the blood. The disease-causing blood-stage of the parasite’s life-cycle is known to be susceptible to antibodies. However, it has proved challenging to translate this knowledge into effective vaccine products. Simon’s group develops novel vaccine technologies and therapeutic human mAbs, to understand vaccine-induced immunity. His expertise includes pre-clinical studies, clinical testing, and human immuno-monitoring. His group has manufactured 9 new vaccines to GMP and undertaken 7 Phase I/IIa clinical trials- all first-in-human or controlled human malaria infection trials. They also assess the human antibody response to important malaria proteins, and this information can then be used to guide the rational design of new and improved vaccine candidates